LEUPRORELIN SANDOZ IMPLANT IN SYRINGE 3.6 MG
Product details
Registration number: SIN16740P
Classification: Prescription Only
Active ingredients: Leuprorelin acetate eqv. Leuprorelin
Strength: 3.6 mg
Dosage form: IMPLANT
Route: SUBCUTANEOUS
Registrant: SANDOZ SINGAPORE PTE. LTD.
ATC code: L02AE02
HSA approval date: 21 March 2023
Manufacturer(s):
- EVER Pharma Jena GmbH
- Synergy Health Radeberg GmbH (Terminal sterilisation)
Manufacturing country/countries: GERMANY
What are the HSA registration number and classification for LEUPRORELIN SANDOZ IMPLANT IN SYRINGE 3.6 MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16740P
Classification: Prescription Only
What active ingredients and strength are recorded for LEUPRORELIN SANDOZ IMPLANT IN SYRINGE 3.6 MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Leuprorelin acetate eqv. Leuprorelin
Strength: 3.6 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for LEUPRORELIN SANDOZ IMPLANT IN SYRINGE 3.6 MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: IMPLANT
Route: SUBCUTANEOUS
Who is the recorded registrant for LEUPRORELIN SANDOZ IMPLANT IN SYRINGE 3.6 MG?
According to the HSA dataset updated 7 August 2026:
Registrant: SANDOZ SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for LEUPRORELIN SANDOZ IMPLANT IN SYRINGE 3.6 MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- EVER Pharma Jena GmbH
- Synergy Health Radeberg GmbH (Terminal sterilisation)
Manufacturing country/countries: GERMANY
Where can I look up LEUPRORELIN SANDOZ IMPLANT IN SYRINGE 3.6 MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16740P or the exact product name LEUPRORELIN SANDOZ IMPLANT IN SYRINGE 3.6 MG. The general register link does not preselect this product.
What are the source dates for this LEUPRORELIN SANDOZ IMPLANT IN SYRINGE 3.6 MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this LEUPRORELIN SANDOZ IMPLANT IN SYRINGE 3.6 MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16740P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)